Abstract
Biopharmaceutical companies that are the subject of this study perform
-
Biopharmaceutical companies that are the subject of this study perform
-
research activities for the drug discovery phase
-
identify therapeutic products for treating human diseases, with
-
novel research technologies that utilize genetic information.
Article Footnote
1The designation “biopharmaceutical company” is used interchangeably with “biotechnology firm/company.”
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grossmann, M. (2003). Independent Biopharmaceutical Companies and their Specialization in Drug Discovery Technologies. In: Entrepreneurship in Biotechnology. Contributions to Management Science. Physica, Heidelberg. https://doi.org/10.1007/978-3-642-57432-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-57432-0_1
Publisher Name: Physica, Heidelberg
Print ISBN: 978-3-7908-0033-3
Online ISBN: 978-3-642-57432-0
eBook Packages: Springer Book Archive